Author

Parker Levitan

University of Miami

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

A. ZunigaiD· 1 shared Arnab ChakrabortyiD· 1 shared Benjamin I. SchachneriD· 1 shared Brooke A. DeRosaiD· 1 shared Derek Michael DykxhoorniD· 1 shared Gulum YenisehirliiD· 1 shared James Jarad DollariD· 1 shared Joshua M. HareiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCell Biology

A. ZunigaORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

LMNA Haploinsufficiency in Human iPSC-Derived Cardiac Organoids Reveals Early Fibrotic Signaling as a Therapeutically Targetable Process

A. Zuniga, Raúl A Dulce, Karina Dutra Asensi, Arnab Chakraborty, Brooke A. DeRosa, Parker Levitan, Sebastian Borges, Renata L. Volonterio, Monica Huerta Lopez, James Jarad Dollar, Gulum Yenisehirli, Sara Rodríguez, Benjamin I. Schachner, Derek Michael Dykxhoorn, Joshua M. Hare, Stefan Kurtenbach

This study uses cardiac organoids derived from patient iPSCs to show that LMNA haploinsufficiency causes early fibrotic signaling, which can be targeted by antifibrotic drugs.

bioRxiv · Oct 22, 2026 · PreprintCell Biology